Literature DB >> 3813588

Efficacy of low-dose cyclosporine in severe atopic skin disease.

T van Joost, E Stolz, F Heule.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3813588     DOI： 10.1001/archderm.123.2.166

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  6 in total

1.  Effects of topical cyclosporin A on guinea-pig toxic contact dermatitis.

Authors:  M Yokoo; D Oka; S Nakagawa
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

Review 2.  Dermatology.

Authors:  M H Rustin
Journal:  Postgrad Med J       Date:  1990-11       Impact factor: 2.401

Review 3.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

4.  The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures.

Authors:  S M McHugh; I R Rifkin; J Deighton; A B Wilson; P J Lachmann; C M Lockwood; P W Ewan
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

5.  Enhanced procoagulant activity of mononuclear leukocytes in patients with atopic dermatitis and psoriasis.

Authors:  R E Schopf; H Weber; B Morsches
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

6.  Severe atopic eczema: response to oral cyclosporin A.

Authors:  R A Logan; R D Camp
Journal:  J R Soc Med       Date:  1988-07       Impact factor: 18.000
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.